NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
1-(cyclohexylamino)propan-2-yl benzoate
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
Cyclaine
|
Hexilcaina [INN-Spanish]
|
Hexylcaine hydrochloride
|
Hexylcainum [INN-Latin]
|
Osmocaine
|
|
|
Synonyms
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
CHEMBL
|
|
Chemspider ID
|
|
DrugBank ID
|
|
KEGG ID
|
|
Unique Ingredient Identifier
|
|
Wikipedia Title
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
H Acceptors
|
2
|
H Donor
|
1
|
LogD (pH = 5.5)
|
0.6174143
|
LogD (pH = 7.4)
|
1.425658
|
Log P
|
3.8281648
|
Molar Refractivity
|
76.2407 cm3
|
Polarizability
|
30.28334 Å3
|
Polar Surface Area
|
38.33 Å2
|
Rotatable Bonds
|
6
|
Lipinski's Rule of Five
|
true
|
Log P
|
3.04
|
LOG S
|
-4.43
|
Solubility (Water)
|
9.71e-03 g/l
|
PROPERTIES
PROPERTIES
Physical Property
Pharmacology Properties
Bioassay(PubChem)
Hydrophobicity(logP)
|
3.9
|
Show
data source
|
|
Half Life
|
<10 minutes
|
Show
data source
|
|
DETAILS
DETAILS
DrugBank
Wikipedia
DrugBank -
DB00473
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Hexylcaine hydrochloride, also called cyclaine (Merck) or osmocaine, is a short-acting local anesthetic. It acts by inhibiting sodium channel conduction. Overdose can lead to headache, tinnitus, numbness and tingling around the mouth and tongue, convulsions, inability to breathe, and decreased heart function. |
Indication |
Used as a local anesthetic for surface application, infiltration or nerve block |
Pharmacology |
Hexylcaine is a local ester-class anesthetic. Local anesthetics produce a transient block of nerve conduction by interfering with sodium channels. This effect of the anesthetic interferes with the development of an action potential across the nerve. |
Toxicity |
Symptoms of anesthetic overdose include headache, tinnitus, circumoral and tongue paresthesias, restlessness, talkativeness, facial twitching, convulsions, respiratory arrest, and cardiac depression |
Affected Organisms |
• |
Humans and other mammals |
|
Biotransformation |
Hydrolyzed by plasma esterases to benzoic acid and other derivatives |
Half Life |
<10 minutes |
External Links |
|
|
PATENTS
PATENTS
PubChem Patent
Google Patent